We suggest that individuals with MLS syndrome or variants or cytogenetic abnormalities involving NDUFB11, HCCS, or COX7B should be considered at risk for histiocytoid CM and screening for evidence of malignant arrhythmias and cardiomyopathy may be appropriate. Here, NDUFB11 is linked to cardiomyopathy.